TY - JOUR
T1 - Implanting the HeartMate 6 (total artificial heart)
AU - Urganci, Erhan
AU - Wiedemann, Dominik
AU - Riebandt, Julia
AU - Schaefer, Anne-Kristin
AU - Hornykewycz, Stephan
AU - Laufer, Guenther
AU - Zimpfer, Daniel
N1 - Publisher Copyright:
© The Author 2021. Published by MMCTS on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
PY - 2021/3/2
Y1 - 2021/3/2
N2 - The HeartMate 3 is a ventricular assist device that supports the heart with a centrifugal continuous flow. It contains a fully levitated rotor to minimize hemolysis and was initially designed as an apical intrapericardial implant. It can be used as a bridge to a transplant, to recovery, or to destination therapy. After we excise the ventricles, we implant 2 HeartMate 3 devices as a total artificial heart (HeartMate 6). The patient was 35 years old when the devices were implanted and had been diagnosed with Yamaguchi syndrome (apical hypertrophic cardiomyopathy) at 13 years of age. Being listed for a transplant was not an option due to secondary pulmonary hypertension. Furthermore, the conventional method of apically implanting a left ventricular assist device was not possible due to the underlying pathology. A HeartMate 6 implant as a bridge to transplant therapy was planned. Additionally, a CardioMEMS HF System was implanted to monitor the pulmonary artery pressure. The video tutorial provides step-by-step instructions for implanting 2 HeartMate 3 devices as a total artificial heart.
AB - The HeartMate 3 is a ventricular assist device that supports the heart with a centrifugal continuous flow. It contains a fully levitated rotor to minimize hemolysis and was initially designed as an apical intrapericardial implant. It can be used as a bridge to a transplant, to recovery, or to destination therapy. After we excise the ventricles, we implant 2 HeartMate 3 devices as a total artificial heart (HeartMate 6). The patient was 35 years old when the devices were implanted and had been diagnosed with Yamaguchi syndrome (apical hypertrophic cardiomyopathy) at 13 years of age. Being listed for a transplant was not an option due to secondary pulmonary hypertension. Furthermore, the conventional method of apically implanting a left ventricular assist device was not possible due to the underlying pathology. A HeartMate 6 implant as a bridge to transplant therapy was planned. Additionally, a CardioMEMS HF System was implanted to monitor the pulmonary artery pressure. The video tutorial provides step-by-step instructions for implanting 2 HeartMate 3 devices as a total artificial heart.
KW - Adult
KW - Heart Failure/surgery
KW - Heart Transplantation/methods
KW - Heart Ventricles/surgery
KW - Heart-Assist Devices
KW - Humans
KW - Male
KW - Prostheses and Implants
UR - https://www.scopus.com/pages/publications/85102843715
U2 - 10.1510/mmcts.2021.012
DO - 10.1510/mmcts.2021.012
M3 - Journal article
C2 - 33691041
SN - 1813-9175
VL - 2021
JO - Multimedia manual of cardiothoracic surgery : MMCTS / European Association for Cardio-Thoracic Surgery
JF - Multimedia manual of cardiothoracic surgery : MMCTS / European Association for Cardio-Thoracic Surgery
ER -
